MIND MEDICINE (MINDMED) INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.52 USD | 0.00% |
|
-1.84% | +132.79% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 3,449 | 590.2 | 82.66 | 146.7 | 600.7 | - | - |
| Enterprise Value (EV) 1 | 3,368 | 456.6 | -59.49 | 61.17 | 416.4 | 501.2 | 393.6 |
| P/E ratio | -30.5 x | -6 x | -1.2 x | -1.5 x | -5.37 x | -5.81 x | -5.97 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - | 178 x |
| EV / Revenue | - | - | - | - | - | - | 117 x |
| EV / EBITDA | -106 x | -5 x | 0.94 x | -0.67 x | -4.75 x | -5.1 x | -3.58 x |
| EV / FCF | -139 x | -9.97 x | 1.19 x | -0.95 x | -5.95 x | -5.92 x | -3.3 x |
| FCF Yield | -0.72% | -10% | 84.3% | -105% | -16.8% | -16.9% | -30.3% |
| Price to Book | - | - | - | 1.83 x | 3.24 x | 5.8 x | 3.32 x |
| Nbr of stocks (in thousands) | 75,377 | 28,511 | 37,571 | 40,095 | 70,501 | - | - |
| Reference price 2 | 45.75 | 20.70 | 2.200 | 3.660 | 8.520 | 8.520 | 8.520 |
| Announcement Date | 3/30/21 | 3/28/22 | 3/9/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | 3.367 |
| EBITDA 1 | - | -31.89 | -91.24 | -63.15 | -90.7 | -87.65 | -98.3 | -110 |
| EBIT 1 | - | - | -93.85 | -66.33 | -93.87 | -95.07 | -110.6 | -131.7 |
| Operating Margin | - | - | - | - | - | - | - | -3,913.24% |
| Earnings before Tax (EBT) 1 | - | -35.34 | -94.19 | -56.8 | -95.73 | -91.58 | -104 | -117.8 |
| Net income 1 | -5.474 | -35.34 | -93.04 | -56.8 | -95.73 | -94.54 | -106 | -120.9 |
| Net margin | - | - | - | - | - | - | - | -3,592.52% |
| EPS 2 | -0.7500 | -1.500 | -3.450 | -1.840 | -2.440 | -1.587 | -1.467 | -1.428 |
| Free Cash Flow 1 | - | -24.18 | -45.82 | -50.14 | -64.36 | -69.95 | -84.7 | -119.2 |
| FCF margin | - | - | - | - | - | - | - | -3,539.11% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/30/20 | 3/30/21 | 3/28/22 | 3/9/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA 1 | -20.01 | -24.29 | -17.72 | -16.12 | -16.19 | -13.11 | -20.07 | -28.39 | -20.82 | -21.42 | -20.05 | -21.05 | -22.65 | -23.9 | - |
| EBIT 1 | -23.28 | -19.2 | -18.5 | -16.94 | -16.98 | -13.9 | -20.86 | -29.18 | -21.62 | -22.2 | -22.09 | -23.13 | -24.33 | -26.22 | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -23.14 | -19.9 | -18.45 | -16.96 | -16.48 | -4.903 | -24.82 | -29.13 | -17.92 | -23.86 | -21.41 | -22.26 | -23.28 | -24.78 | - |
| Net income 1 | -23.14 | -18.75 | -18.45 | -16.96 | -16.48 | -4.903 | -24.82 | -29.13 | -17.92 | -23.86 | -25.76 | -21.48 | -22.65 | -25.25 | - |
| Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EPS 2 | -0.9000 | -0.7500 | -0.6000 | -0.6000 | -0.5600 | -0.0200 | -0.6500 | -0.7600 | -0.4500 | -0.5900 | -0.5433 | -0.3600 | -0.3767 | -0.4133 | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/12/21 | 3/28/22 | 5/16/22 | 8/11/22 | 11/10/22 | 3/9/23 | 5/4/23 | 8/3/23 | 11/2/23 | 2/28/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 80.1 | 134 | 142 | 85.6 | 184 | 99.5 | 207 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -24.2 | -45.8 | -50.1 | -64.4 | -70 | -84.7 | -119 |
| ROE (net income / shareholders' equity) | - | - | - | - | -83.6% | -65% | -70.1% | -70.7% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share 2 | - | - | - | - | 2.000 | 2.630 | 1.470 | 2.570 |
| Cash Flow per Share 2 | - | - | - | - | -1.640 | -0.8700 | -1.080 | -1.000 |
| Capex 1 | - | - | - | - | - | 4 | 10 | 12.5 |
| Capex / Sales | - | - | - | - | - | - | - | 371.29% |
| Announcement Date | 3/30/20 | 3/30/21 | 3/28/22 | 3/9/23 | 2/28/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
8.52
USD
Average target price
30.86
USD
Spread / Average Target
+262.17%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +132.79% | 601M | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| +49.22% | 41.61B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- MNMD Stock
- Financials Mind Medicine (MindMed) Inc.
